Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States

Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States

Gonadotropin-releasing hormone agonists (GnRHa's) are the standard treatment for children with central precocious puberty (CPP). We aim to present data on available GnRHa options with an easy-to-review table and discuss factors that influence treatment selection. Five GnRHa's are currently...

Full description

Bibliographic Details
Main Authors: Jadranka Popovic, Mitchell E. Geffner, Alan D. Rogol, Lawrence A. Silverman, Paul B. Kaplowitz, Nelly Mauras, Philip Zeitler, Erica A. Eugster, Karen O. Klein
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Pediatrics
Subjects:
central precocious puberty (CPP)
gonadotropin-releasing hormone (GnRH) agonists
leuprolide acetate
triptorelin pamoate
histrelin acetate
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.968485/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2022.968485/full

Similar Items